There was an association between decreased BIRC5 expression and improved clinical outcomes due to inv(16) but this same association was not seen with t(8;21) patients despite AML-ETO being a critical regulator of BIRC5 in AML [41]. Here, RUNX1T1 is linked to acute myeloid leukemia.